Literature DB >> 2344217

Amyloidosis in rheumatic diseases.

J Barash.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2344217      PMCID： PMC1004084          DOI： 10.1136/ard.49.5.337-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Colchicine therapy of the renal amyloidosis of ulcerative colitis.

Authors:  S Meyers; H D Janowitz; V V Gumaste; R G Abramson; L J Berman; V S Venkataseshan; S H Dickman
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

Review 2.  Amyloidosis in the rheumatic diseases.

Authors:  V Dhillon; P Woo; D Isenberg
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

3.  Colchicine inhibition of serum amyloid protein SAA and SAP synthesis in primary mouse liver cell cultures.

Authors:  E Tatsuta; J D Sipe; T Shirahama; M Skinner; A S Cohen
Journal:  Arthritis Rheum       Date:  1984-03

4.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

5.  Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973).

Authors:  A S Cohen; A Rubinow; J J Anderson; M Skinner; J H Mason; C Libbey; H Kayne
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.